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Background/Aims
The aim of this study is to identify the alteration in intestinal permeability with regard to the development of post-operative ileus (POI). 
Moreover, we investigated drug repositioning in the treatment of POI.
Methods
An experimental POI model was developed using guinea pigs. To measure intestinal permeability, harvested intestinal membranes of 
the ileum and proximal colon was used in an Ussing chamber. To identify the mechanisms associated with altered permeability, we 
measured leukocyte count and expression of calprotectin, claudin-1, claudin-2, and mast cell tryptase. We compared control, POI, and 
drug groups (mosapride [0.3 mg/kg and 1 mg/kg, orally], glutamine [500 mg/kg, orally], or ketotifen [1 mg/kg, orally] with regard to 
these parameters. 
Results
Increased permeability after surgery significantly decreased after administration of mosapride, glutamine, or ketotifen. Leukocyte 
counts increased in the POI group and decreased significantly after administration of mosapride (0.3 mg/kg) in the ileum, and 
mosapride (0.3 mg/kg and 1 mg/kg), glutamine, or ketotifen in the proximal colon. Increased expression of calprotectin after surgery 
decreased after administration of mosapride (0.3 mg/kg), glutamine, or ketotifen in the ileum and proximal colon, and mosapride 
(1 mg/kg) in the ileum. The expression of claudin-1 decreased significantly and that of claudin-2 increased after operation. After 
administration of glutamine, the expression of both proteins was restored. Finally, mast cell tryptase levels increased in the POI group 
and decreased significantly after administration of ketotifen.
Conclusions
The alteration in intestinal permeability is one of the factors involved in the pathogenesis of POI. We repositioned 3 drugs (mosapride, 
glutamine, and ketotifen) as novel therapeutic agents for POI.
(J Neurogastroenterol Motil 2021;27:639-649)
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Introduction  
Post-operative ileus (POI) is the temporary cessation of co-
ordinated propulsive movement after most surgical procedures.1,2 
Because of this iatrogenic condition, patients present with various 
symptoms such as nausea, vomiting, abdominal discomfort, and 
inability to pass stools or tolerate a solid diet. In addition to these 
symptoms, decreased quality of life, prolonged length of stay in a 
hospital, and socioeconomic costs decrease patients’ satisfaction with 
surgery. Although there have been attempts to improve POI, such 
as the conversion of the surgical method from open to laparoscopic 
surgery and the chewing of gum, POI is still one of the main prob-
lems faced by patients who undergo surgical procedures.3,4 More-
over, there is currently no definite method for the prevention and 
treatment of POI. To suggest effective management, the precise 
mechanisms underlying POI need to be investigated. 
Meanwhile, there are several diseases associated with the altera-
tion in gut permeability. These diseases include inflammatory bowel 
disease, malignancies, irritable bowel syndrome, rheumatic disor-
ders, obesity-related metabolic diseases, and allergic diseases.5-9 In 
these diseases, several factors such as inflammation, tight junction 
(TJ) proteins, and gut dysbiosis have an effect on the alteration in 
intestinal permeability. For instance, in inflammatory bowel disease, 
the permeation of luminal noxious materials via the disruption of 
intestinal TJ proteins such as claudin causes defects in the mucosal 
immune system and inflammation.10,11 
A previous study reported that intestinal inflammation and 
TJ proteins are associated with POI.12 In the study, inflammatory 
markers significantly increased in the POI group, compared with 
that in the control group. Moreover, of the TJ proteins, the levels 
of barrier-forming protein (claudin-1) decreased and pore-forming 
protein (claudin-2) increased in the POI group. Therefore, we 
hypothesized that the alteration in intestinal permeability is also as-
sociated with POI. However, studies investigating the association 
between POI and intestinal permeability are limited.
Therefore, in this study, we aim to characterize the alteration in 
intestinal permeability as a pathophysiologic mechanism of POI. 
Furthermore, we investigated drug repositioning in the treatment of 
POI.
Materials and Methods  
Animals, Abdominal Operation, and Drugs
In this study, we used adult male Hartley guinea pigs (Orient 
Bio Inc, Seoul, Korea) weighing 300-350 g. The guinea pigs were 
housed under controlled breeding conditions (temperature of 22 
± 2°C, humidity of 50 ± 10%, and 12-hour light/dark cycle start-
ing at 7 AM). All the experimental procedures were reviewed and 
approved by the Institutional Animal Care and Use Committee, 
Department of Laboratory Animal Resources, Yonsei Biomedical 
Research Institute, Yonsei University College of Medicine (IRB 
No. 2017-0344).
The guinea pigs were randomly assigned into 3 groups. The 
first group was the “control group,” which did not receive any 
manipulation or drugs. The second was the “POI group,” which 
was subjected to surgical procedures as follows: an incision, fol-
lowed by evisceration, gentle manipulation of the cecum using wet 
gauze for 60 seconds, and closing of the incision by suturing. The 
third was the “drug group,” which received drugs, and this group 
was divided into the mosapride, glutamine, and ketotifen groups. 
The mosapride group was administered 0.3 mg/kg or 1 mg/kg of 
mosapride via the oral route 1 hour before and after the operation. 
The glutamine group received 500 mg/kg of glutamine orally 4, 3, 
2, and 1 day before the operation. Finally, the ketotifen group was 
administered 1 mg/kg of ketotifen orally 4, 3, 2, and 1 day before 
the operation. We determined the dosages of these drugs as per 
previous animal studies.13-15 The number of guinea pigs for each 
group was 7. We harvested the ileum and proximal colon from each 
guinea pig. In the POI and drug groups, we harvested tissues 3 
hours (POI 3H) and 6 hours (POI 6H) after surgery.
Methods
We measured various markers in the harvested ileum and 
proximal colon. An Ussing chamber (EM-CSYS-2; Physiologic 
Instruments, Sandiego, CA, USA) was used to analyze intestinal 
permeability, and we measured the leukocyte count and the expres-
sion of calprotectin to evaluate intestinal inflammation. The expres-
sion of mast cell tryptase was evaluated to identify the effect of keto-
tifen as a mast cell stabilizer. Moreover, we measured the expression 
of claudin-1 and claudin-2 to evaluate alterations in TJ proteins. We 
compared the measurements between the control and POI groups 
and between the POI and drug groups. The detailed methods of 
measurement are described as follows.
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Intestinal Permeability
To evaluate intestinal permeability, the harvested tissues were 
placed in a modified Ussing chamber. Two mL Krebs-Ringer 
bicarbonate (KRB) solution were filled in each half chamber, and 
the specimen’s mucosal and serosal sides were bathed. At the main-
tained temperature of 37°C, a gas mixture of 95% O2 and 5% CO2 
was given to both sides. After an equilibration period of 30 minutes, 
the KRB containing horseradish peroxidase (HRP) at a final con-
centration of 0.4 mg/mL was substituted for the KRB in the cham-
ber of the mucosal side. The KRB on the serosal side was replaced 
with fresh KRB, and a 0.3 mL sample was gathered and replaced 
with 0.3 mL KRB of the serosal side. The samples from the cham-
ber of serosal side were enzymatically analyzed via the modified 
Worthington method. We used o-dianisidine dihydrochloride 
(OPD; Sigma Chemical Co, St Louis, MO, USA) as a substrate. 
Samples (50 μL) were transferred to microtiter, and OPD working 
solution (100 μL) as a stable peroxide buffer, which was diluted 
1:10 in OPD, was added to each well. Subsequently, the plates were 
incubated with shaking at 300 rpm and room temperature. Thirty 
minutes later, 2.5 M sulfuric acid (100 μL) was added. After 10 
minutes, using a microplate reader (Model 680; Bio-Rad Labora-
tories, Inc, Hercules, CA, USA), the decolorized reaction product’s 
absorbance was determined at a wavelength of 492 nm. All samples 
were duplicated and measured with reference to a standard curve. 
HRP flux was represented as ng/2 hr/mm2 during steady-state 
permeation. Intestinal permeability via the Ussing chamber was ex-
pressed as the percentage change compared with the control group.
Leukocyte Count
Histological sections were obtained from the muscle layer of 
the harvested ileum and proximal colon. These sections were fixed 
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Figure 1. Intestinal permeability in the control, post-operative ileus (POI), and drug groups. (A) Three hours after the operation and (B) 6 hours 
after the operation. The data are expressed as a percentage change relative to the control group. Bars indicate the mean ± SEM (control group, n 
= 7; POI group, n = 7; each drug group, n = 7). *P < 0.05. POI 3H, post-operative ileus at 3 hours after the operation; POI 6H, post-opera-
tive ileus at 6 hours after the operation; MOS, mosapride; GLN, glutamine; KET, ketotifen. 
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in 10% neutral buffered formalin solution and then embedded 
with paraffin. Embedded sections were sliced into 4 μm thickness 
and then hematoxylin and eosin staining. We compared leukocyte 
counts between the control and POI groups and between POI and 
drug groups via a semi-quantitative scoring system. 
Expression of Calprotectin and Mast Cell Tryptase
The expression of calprotectin and mast cell tryptase was deter-
mined via immunohistochemical analysis. The paraffin-embedded 
histological tissue sections from the ileum and proximal colon were 
deparaffinized. Tissue sections were incubated in 3% hydrogen 
peroxide for 10 minutes to block activity of endogenous peroxidase. 
The tissue sections were then incubated overnight with primary 
antibodies, anti-calprotectin (1:250; ThermoFisher, Waltham, MA, 
USA) and anti-mast cell tryptase (1:2000; ThermoFisher), 4°C. 
After 3 washes with phosphate-buffered saline, the tissue sections 
were incubated with secondary antibody anti-mouse IgG (1:200; 
Vector Laboratories). Next, the sections were incubated with strep-
tavidin-HRP for 30 minutes and then treated with AB-peroxidase 
solution and counterstaining with hematoxylin. Images were ana-
lyzed via MetaMorph (MDS Analytical Technologies, Sunnyvale, 
CA, USA).
Expression of Claudin-1 and Claudin-2
The expression of claudin-1 and claudin-2 was determined via 
immunofluorescence analysis. At 6 hours after the operation, the 
histological sections from the ileum and proximal colon were fixed 
in 4% paraformaldehyde, embedded with paraffin, and sliced into 
4 μm thick sections. Tissues then were deparaffinized, rehydrated, 















































































































































Figure 2. Leukocyte counts in the control, post-operative ileus (POI), and drug groups. (A) Three hours after the operation and (B) 6 hours af-
ter the operation. The data were analyzed using a semi-quantitative scoring system. Bars indicate the mean ± SEM (control group, n = 7; POI 
group, n = 7; each drug group, n = 7). *P < 0.05. POI 3H, post-operative ileus at 3 hours after the operation; POI 6H, post-operative ileus at 6 
hours after the operation; MOS, mosapride; GLN, glutamine; KET, ketotifen. 
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cubated overnight with the primary antibody for claudin-1 (1:50; 
Invitrogen, South San Francisco, CA, USA) or claudin-2 (1:200; 
Invitrogen) at 4°C, followed by washing and incubation with the 
secondary antibody goat anti-rabbit IgG-fluorescein isothiocyanate 
(1:200; Santa Cruz Biotechnology) for 30 minutes at 37°C. The 
stained samples were evaluated under a fluorescence microscope 
(Zeiss Axio Imager Z1; Carl Zeiss, Jena, Germany), and the im-
ages were analyzed via MetaMorph. 
Statistical Methods
The data were expressed as the mean ± SE, and statistical 
analysis was performed using a t test or Wilcoxon rank-sum test 
between the 2 groups and a one-way ANOVA for multiple com-
parisons. For statistical analysis, we used SPSS version 23.0 (IBM 
Corp, Armonk, NY, USA). A two-tailed P-value of < 0.05 indi-
cated statistical significance. 
Results  
Intestinal Permeability
Figure 1 shows the result of intestinal permeability. The intes-
tinal permeability in the POI 3H samples was significantly higher 
than that in the control group of the ileum and proximal colon (P 
< 0.05). The administration of mosapride, glutamine, or ketotifen 
significantly decreased the permeability (P < 0.05) (Fig. 1A). 
There was a significant increase in the permeability of the POI 6H 
ileum and proximal colon, compared with that of the control group 
(P < 0.05) (Fig. 1B). This increase was significantly reversed after 
the administration of mosapride, glutamine, or ketotifen (P < 0.05). 
Leukocyte Count 
The leukocyte counts in the POI 3H ileum and proximal colon 
were significantly higher than that in the control group (P < 0.05). 
The leukocyte count decreased significantly after the administration 
of mosapride (0.3 mg/kg) (P < 0.05) (Fig. 2A). The leukocyte 
counts in the POI 6H ileum and proximal colon were significantly 
higher than that in the control group (P < 0.05). After the admin-
istration of mosapride (0.3 mg/kg), the leukocyte count decreased 
significantly in the ileum (P < 0.05). Moreover, the leukocyte 
count decreased significantly after the administration of mosapride, 
glutamine, or ketotifen in the proximal colon (P < 0.05) (Fig. 2B).
Expression of Calprotectin 
There was a significant increase for the expression of calpro-
tectin in the POI 3H of the ileum and proximal colon, compared 
with that in the control group (P < 0.05) (Fig. 3A). In the POI 
3H group of the ileum, the expression of calprotectin significantly 
decreased after the administration of mosapride, glutamine, or ke-
totifen (P < 0.05). The expression of calprotectin in the POI 6H 
group ileum and proximal colon was significantly higher than that 
in the control group (P < 0.05), and it decreased significantly after 
the administration of mosapride (0.3 mg/kg), glutamine or ketoti-
fen (P < 0.05) (Fig. 3B).
Expression of Mast Cell Tryptase
There was no significant change for the expression of mast cell 
tryptase in the POI 3H and 6H ileum (Fig. 4A). There was a sig-
nificant increase for the expression of mast cell tryptase in the POI 
3H and POI 6H proximal colon compared with that in the control 
group (P < 0.05). Moreover, the expression of mast cell tryptase in 
the proximal colon decreased significantly after the administration 
of ketotifen (P < 0.05). Figure 4B and 4C show representative im-
munohistochemical images of mast cell tryptase in the control, POI, 
and ketotifen groups.
Expression of Claudin-1 and Claudin-2 
The expression of claudin-1 in the POI 3H group ileum 
and proximal colon decreased significantly, compared with that in 
the control group (P < 0.05). After the administration of gluta-
mine, the expression of claudin-1 in the ileum and proximal colon 
improved significantly (P < 0.05) (Fig. 5A). The expression of 
claudin-1 was significantly downregulated in the ileum and proxi-
mal colon of the POI 6H group (P < 0.05), which improved 
significantly (P < 0.05) after the administration of glutamine (Fig. 
5B). Representative images of claudin-1 via immunofluorescence 
staining in the control, POI, and glutamine groups are shown in 
Supplementary Figure 1A (POI 3H) and 1B (POI 6H).
The expression of claudin-2 in the ileum and proximal colon of 
the POI 3H and 6H groups increased significantly compared with 
that in the control group (P < 0.05) and was significantly restored 
after the administration of glutamine in the ileum and proximal co-
lon (Fig. 5C and 5D). Representative immunofluorescence images 
of claudin-2 in the control, POI, and glutamine groups are shown 
in Supplementary Figure 2A (POI 3H) and 2B (POI 6H).
Discussion  
This study demonstrated that intestinal permeability increased 
significantly in POI guinea pig models, compared with that in con-
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trol pigs. Moreover, mosapride, glutamine, and ketotifen effectively 
reduced the observed permeability. To the best of our knowledge, 
this is the first study to identify alterations in intestinal permeability 
as an important mechanism associated with POI. Moreover, this 
study evaluated not only intestinal permeability but also possible 
factors contributing to the alteration in permeability. 
We created POI guinea pig models at 3 hours and 6 hours post 
operation. In a previous study, the degree of POI, which was evalu-
ated by the level of gas distention, peaked at 3 hours and resolved 
at 6 hours after the operation.16 Therefore, these 2 time points are 
appropriate for evaluating the early stage of POI. Although the re-
covery time of POI differs with the different portions of the gastro-
intestinal tract,12,17 the permeability of the ileum and proximal colon 
increased at both 3 hours and 6 hours post operation in the present 
study. These findings suggest that the alteration in permeability lasts 
longer than the contractile activity. Because increased permeability 
leads to the translocation of bacteria and toxins through the intesti-
nal mucosa, it is important to regulate the alteration in gut perme-
ability in post-operative conditions.
 The most prominent increase in permeability was observed in 
the POI 6H ileum. Among factors such as leukocytes, calprotectin, 
claudin, and mast cell tryptase, the expression of claudin showed the 
most significant change in the POI 6H ileum. Thus, TJ proteins 
may be the most important factor involved in the alteration in per-
meability. 
After the administration of mosapride, glutamine, or ketotifen, 
the intestinal permeability decreased significantly. The dosages 
of the drugs were determined based on previous animal studies. 
Mosapride (0.3 mg/kg and 1 mg/kg) attenuated intestinal inflam-
mation and motility dysfunction in a POI rat model.13 In the case 
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Figure 3. Expression of calprotectin in the control, post-operative ileus (POI), and drug groups. (A) Three hours after the operation and (B) 6 
hours after the operation. The average intensity of the expression of calprotectin was analyzed via MetaMorph microscopy automation. Bars indi-
cate the mean ± SEM (control group, n = 7; POI group, n = 7; each drug group, n = 7). *P < 0.05. POI 3H, post-operative ileus at 3 hours 
after the operation; POI 6H, post-operative ileus at 6 hours after the operation; MOS, mosapride; GLN, glutamine; KET, ketotifen. 
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of glutamine, a previous study evaluated the effect of glutamine 
(500 mg/kg) on intestinal permeability in a post-operative murine 
model.14 It was observed that glutamine decreased intestinal per-
meability and bacterial translocation, thereby preserving barrier 
integrity. Another study evaluated the role of ketotifen as a mast cell 
stabilizer for inflammation in a mouse model of POI15 and reported 
that 1 mg/kg of ketotifen prevented surgery-induced inflammation 
and gastroparesis.
To identify the mechanisms associated with the alteration in 
permeability, we evaluated inflammatory markers and TJ proteins, 
which are known to have an effect on intestinal permeability. In the 
present study, the leukocyte count and the expression of calprotec-
tin, as inflammatory markers, increased significantly in the ileum 
and proximal colon of the POI group. The degree of increase in 
these inflammatory markers was prominent in the proximal colon 
at 6 hours post operation, and this result was consistent with that of 
a previous study.12 This result may be associated with the difference 
in the recovery time of the ileus in that the contractile activity of the 
proximal colon lasted longer than that of the ileum. 
Among the 3 drugs selected, mosapride was the most effec-
tive against inflammation. Mosapride is well known as a prokinetic 
5-hydroxytryptamine 4 (5-HT4) receptor agonist. In addition 
to the prokinetic effect, mosapride has an anti-inflammatory ef-
fect medicated by acetylcholine release for cholinergic myenteric 
neurons.13,15,18 The released acetylcholine binds to the α7 nicotinic 
receptor on activated macrophages, thereby preventing leukocyte 
infiltration. Notably, the anti-inflammatory effect of mosapride was 
attenuated in a higher dose (1 mg/kg) compared with lower dose 
(0.3 mg/kg) of mosapride. The possible explanation of this result 
may be the desensitization of 5-HT4 receptors located on sensory 
neurons in the presence of a higher concentration of 5-HT4 recep-
tor agonists. Previous studies reported the desensitization of tegas-
erod, which is another 5-HT4 receptor agonist. One in vitro study 
showed that a higher dose of tegaserod did not cause an increase 
of velocity for fecal propulsion in the guinea pig.19 Another study 
demonstrated that the effect of tegaserod to elicit the desensitization 
A Ileum Proximal colon




































































































Figure 4. Expression of mast cell tryptase in the control, post-operative ileus (POI), and ketotifen groups. (A) The average intensity of the expres-
sion of calprotectin was analyzed via MetaMorph microscopy automation. Representative immunohistochemical staining of mast cell tryptase for 
POI at 3 hours after the operation (POI 3H) (B) and POI at 6 hours after the operation (POI 6H) (C). Bars indicate the mean ± SEM (control 
group, n = 7; POI group, n = 7; ketotifen group, n = 7). *P < 0.05. KET, ketotifen.
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was dependent on the concentration of tegaserod.20 Further study is 
need to evaluate whether mosapride desensitizes the 5-HT4 recep-
tor at a higher dose in the guinea pig. In addition to mosapride, 
glutamine and ketotifen also showed anti-inflammatory effects 
in the POI model in the present study. Glutamine exhibits anti-
inflammatory effects by modulating the inflammatory signaling 
pathways such as the nuclear factor κB and signal transducer and 
activator of transcription pathways.21 Moreover, ketotifen exerts an 
anti-inflammatory effect that is mediated by its ability to decrease 
the production of pro-inflammatory mediators, such as nitric oxide, 
interleukin-1b, and interleukin-6.22,23 
In addition to leukocytes and macrophages, mast cells are also 
associated with inflammation in the pathogenesis of POI. Intesti-
nal manipulation induces mast cell degranulation, followed by the 
activation of resident intestinal macrophages. This promotes the 
phosphorylation of transcription factors and consequently the secre-
tion of cytokines and chemokines, which induce the upregulation 
of endothelial adhesion molecules and the influx of leukocytes.24,25 
Mast cell tryptase is one of the granules (such as histamine, pros-
taglandin, and cytokines) released from activated mast cells.26,27 In 
our study, the expression of mast cell tryptase increased significantly 
in the proximal colon, which was effectively decreased by ketotifen. 
Ketotifen is a mast cell-stabilizing agent that blocks the release of 
mast cell granules.28 
Epithelial TJs are multiple protein complexes that maintain the 
intestinal barrier while regulating the permeability of ions, water, 
and nutrients.29 Of the 4 integral transmembrane proteins—occlu-
din, claudins, junctional adhesion molecules, and tricelluin, claudins 
are classified as a barrier-forming or pore-forming proteins.30,31 
Claudin-1 and claudin-2 are known to be predominantly barrier-
forming and pore-forming proteins, respectively.32,33 In this study, 
the expression of claudin-1 and -2 changed significantly in the POI 
A Ileum Proximal colon
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Figure 5. Expression of claudin in the control, post-operative ileus (POI), and drug groups. (A) Claudin-1 in the 3 hours after the operation, (B) 
claudin-1 in the 6 hours after the operation, (C) claudin-2 in the 3 hours after the operation, and (D) claudin-2 in the 6 hours after the operation. 
The average intensity of the expression of calprotectin was analyzed via MetaMorph microscopy automation. Bars indicate the mean ± SEM 
(control group, n = 7; POI group, n = 7; each drug group, n = 7). *P < 0.05. POI 3H, post-operative ileus at 3 hours after the operation; POI 
6H, post-operative ileus at 6 hours after the operation; MOS, mosapride; GLN, glutamine; KET, ketotifen.
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3H and POI 6H ileum and proximal colon. Moreover, glutamine 
had a significant effect on the levels of claudin-1 and -2 in both the 
ileum and proximal colon. Glutamine maintains intestinal tissue 
integrity, and one of the several mechanisms associated with this 
function is the induction of the expression of TJ proteins such as 
claudin-1, occludin, and zonula occludens.34 
Based on our study results, mosapride, glutamine, and ketotifen 
are potential therapeutics for POI in clinical settings. Mosapride 
is widely prescribed as a prokinetic agent for dyspepsia and has 
proven safety. As mentioned earlier, in addition to its prokinetic ef-
fect, mosapride has an anti-inflammatory effect, which explains its 
ability to reduce intestinal permeability in this study. Therefore, it is 
necessary to determine whether the inflammation and symptoms of 
POI are improved after mosapride administration.
A recent study reported the induction of gut bacterial dysbiosis 
in a guinea pig POI model.35 In that study, bowel movement was 
restored upon treatment with probiotics. Another study reported 
that gut dysbiosis leads to the disruption of intestinal integrity and 
the development of intestinal inflammation.36 Therefore, in addi-
tion to inflammation and TJ proteins, other factors such as the gut 
microbiota may also have an effect on intestinal permeability. Future 
studies investigating the association between the microbiota and 
permeability are warranted to clarify our findings.
In conclusion, altered intestinal permeability is one of the fac-
tors involved in the pathogenesis of POI. Moreover, changes in 
the expression of inflammatory markers such as leukocytes, calpro-
tectin, and mast cell tryptase, and TJ proteins were also observed 
in the POI model. Mosapride, glutamine, and ketotifen exhibited 
anti-inflammatory effects, thereby modulating intestinal permeabil-
ity. Notably, glutamine had an effect on TJ proteins and ketotifen 
had an effect on mast cells. Therefore, we repositioned the 3 drugs 
as novel and potential therapeutic agents for POI. 
Supplementary Materials  
Note: To access the supplementary figures mentioned in this 
article, visit the online version of Journal of Neurogastroenterol-
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